Official Book Launch and Symposium:
Leveraging the Data Revolution to Build the Drug Development Pipeline
June 1, 2016 • 4:00-8:00 pm • The New York Academy of Sciences
Join us to celebrate the publication of
Scroll down for Symposium Details and Bios
William T. Loging, Ph.D.
Associate Professor Genetics/Genomic Sciences
Head of Production Bioinformatics
Mount Sinai School of Medicine
At this official launch, we will hear from key thought leaders who are both contributing to the rapid growth of medical understanding, and are influenced by Dr. Loging's work: Eric Schadt and Richie Etwaru
4:00 - Arrival 4:30 - Program Begins:
William Loging, Eric Schadt, and Richie Etwaru Discussions
6:00 - Reception Begins 8:00 - Adjourn
Dr. Loging has spent the past 20 years focusing on generating treatments for human disease.
Bridging both clinical genomics and pharmaceutical sciences, he have been globally recognized for his work with Maraviroc (Selzentry™) for use in HIV. The results of past his contribution to the approval of Empagliflozin (Jardiance™) were listed within the drug insert. He has published in several leading scientific journals on utilization of novel informatics approaches to Drug Discovery and his 2014 TEDx talk on
Cancer Genomics was highly acclaimed.
He currently holds several appointments at the Mt Sinai School of Medicine where he focuses on the clinical fields of Oncology and Immunology of which he holds several patents. William is also an External Researcher Collaborator of James Cook University's Centre for Biodiscovery and Molecular Development of Therapeutics (CBMDT) in Cairns, Australia. Additionally, he served for six year in the US Marine Corps and was meritoriously promoted for leadership and outstanding dedication to duty.
Eric Schadt, Ph.D.
Director of the Icahn Institute for Genomics and Multiscale Biology
Chair of the Department of Genetics and Genomics Sciences
Jean C. & James W. Crystal Professor of Genomics
Icahn School of Medicine at Mount Sinai.
Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology in order to more accurately model the complexity of biological systems.
He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease.
Chief Digital Officer
Dr. Etwaru is helping bridge the innovation and efficiency gap for healthcare stakeholders and life sciences customers using analytics and technology. He joined IMS Health as part of the Cegedim acquisition where he served in the same chief digital officer capacity.
Before that, Richie worked for UBS Wealth Management and Barclays where he focused on innovation and technology. Richie is also a serial entrepreneur who has started several companies, as well as an author and regular contributor to Forbes.com and Huffington Post.